Anebulo Pharmaceuticals Inc (ANEB) Stock Analysis

Anebulo Pharmaceuticals Inc (ANEB) is a publicly traded company in the HEALTHCARE sector. It trades at $0.43. This page summarizes the public market data, fundamentals, and frequently asked questions for ANEB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.43

Market Sentiment

Anebulo Pharmaceuticals Inc currently has a Neutral sentiment score of 0.02.

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Lakeway, Texas, dedicated to addressing urgent medical needs in cannabinoid overdose and addiction treatment. With a proprietary drug development platform, Anebulo is advancing a differentiated product pipeline aimed at combating substance use disorders, a critical area of healthcare demand. The company's strategic focus on innovative therapeutics positions it as a potential leader in improving patient ou...

GNG Research Analysis

GNG Research scores Anebulo Pharmaceuticals Inc (ANEB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANEB.

Frequently Asked Questions

Does ANEB pay dividends?

Anebulo Pharmaceuticals Inc (ANEB) does not currently pay a regular dividend.